Related Experiment Video
Updated: Apr 18, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A
Vanda S Lopes1, David S Williams1
1Stein Eye Institute, University of California at Los Angeles, Los Angeles, California 90095-7000.
Abstract:
Usher syndrome is a deaf-blindness disorder. One of the subtypes, Usher 1B, is caused by loss of function of the gene encoding the unconventional myosin, MYO7A. A variety of different viral-based delivery approaches have been tested for retinal gene therapy to prevent the blindness of Usher 1B, and a clinical trial based on one of these approaches has begun. This review evaluates the different approaches.
More Related Videos
Related Concept Videos
Gene Therapy
Gene Therapy
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene

